DSP-3077
/ Riken, Sumitomo Pharma, RACTHERA
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 24, 2025
A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa
(clinicaltrials.gov)
- P1/2 | N=12 | Recruiting | Sponsor: Sumitomo Pharma America, Inc. | Not yet recruiting ➔ Recruiting | Initiation date: May 2025 ➔ Oct 2025
Enrollment open • Trial initiation date • Genetic Disorders • Inherited Retinal Dystrophy • Ocular Inflammation • Ophthalmology • Retinal Disorders • Retinitis Pigmentosa
March 24, 2025
A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older with Retinitis Pigmentosa
(clinicaltrials.gov)
- P1/2 | N=12 | Not yet recruiting | Sponsor: Sumitomo Pharma America, Inc.
New P1/2 trial • Genetic Disorders • Inherited Retinal Dystrophy • Ocular Inflammation • Ophthalmology • Retinal Disorders • Retinitis Pigmentosa
1 to 2
Of
2
Go to page
1